Federal award (DELIVERY ORDER, fiscal year 2024)
Recipient: DMS PHARMACEUTICAL GROUP INC
Awarding agency: Department of Defense / Defense Logistics Agency
Funding agency: Department of Defense / Defense Logistics Agency
Period of performance: 2025-04-02 to 2025-04-17
Current total value of award: $13005.98
Description: 4567774527!ATEZOLIZMAB 60MG/ML 1S